Tag

NASDAQ: INCY

Genmab and Incyte agree to colorectal cancer combination trial
Adrian Kessler · Oct 24, 2026
Edesa Biotech gains FDA clearance to expand Phase 2 vitiligo trial
Adrian Kessler · Oct 16, 2026
Egetis Therapeutics AB wins FDA approval for Emcitate in MCT8 deficiency
Adrian Kessler · Sep 29, 2026
Mirum Pharmaceuticals wins FDA approval for Atebrioz in FOP patients 12 and older
Adrian Kessler · Sep 26, 2026